| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $-0.19 (Beat by $0.73) |
| EPS GAAP Actual | $-0.19 (Beat by $0.73) |
| Revenue Actual | $1.32999B |
| Revenue Surprise | Beat by $1329.99M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.09296 |
| EPS GAAP Estimate | $2.09296 |
| Revenue Estimate | $1.785923666B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 1 |
| Dec 2028 | 29.8 | 3.26 | 24.63464 | 39.91366 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.16 | -2.01977 | 1.32999B | -7.55% | -240.97M |
| FQ1 2025 (Mar 2025) | -0.0029 | -0.0029 | 1.07688B | -26.36% | 1076.88M |
| FQ4 2024 (Dec 2024) | 0.29 | 0.29 | 1.23171B | -91.29% | 1231.71M |
| FQ3 2024 (Sep 2024) | -9.45 | -9.45 | 1.35469B | -70.56% | 1354.69M |
| FQ2 2024 (Jun 2024) | -3.94 | -3.94 | 1.43039B | -65.7% | 1430.39M |
| FQ1 2024 (Mar 2024) | -1.4 | -1.4 | 1.36074B | -89.62% | 1360.74M |
| FQ4 2023 (Dec 2023) | -5.26 | -5.26 | 2.35617B | 100% | 2356.17M |
| FQ3 2023 (Sep 2023) | 2.58 | 2.58 | 2.3106B | 9.47% | 2310.6M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.09296
Consensus Revenue Estimates
1.785923666B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.37775 | -- | 0.35099 | 0.4161 | 7 |
| FQ3 2027 (Sep 2027) | 1.2583 | -- | 1.19897 | 1.34598 | 1 |
| FQ2 2027 (Jun 2027) | 1.18572 | -- | 1.12982 | 1.26834 | 1 |
| FQ1 2027 (Mar 2027) | 0.58603 | -- | 0.5584 | 0.62687 | 1 |
| FQ4 2026 (Oct 2026) | 2.64677 | -- | 2.06179 | 3.47 | 5 |
| FQ3 2026 (Jul 2026) | 2.29774 | -- | 1.7899 | 3.01241 | 5 |
| FQ2 2026 (Jun 2026) | 2.04123 | 107.84 | 1.56453 | 2.60593 | 4 |
| FQ1 2026 (Mar 2026) | 1.66567 | 100.17 | 1.27939 | 2.20066 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.49B | -- | 1.41B | 1.6B | 7 |
| FQ3 2027 (Sep 2027) | 1.74B | -- | 1.68B | 1.84B | 2 |
| FQ2 2027 (Jun 2027) | 1.7B | -- | 1.64B | 1.79B | 2 |
| FQ1 2027 (Mar 2027) | 1.51B | -- | 1.45B | 1.59B | 2 |
| FQ4 2026 (Oct 2026) | 2.25B | -- | 1.87B | 2.79B | 8 |
| FQ3 2026 (Jul 2026) | 2.07B | -- | 1.71B | 2.56B | 5 |
| FQ2 2026 (Jun 2026) | 1.92B | 30.68 | 1.57B | 2.33B | 4 |
| FQ1 2026 (Mar 2026) | 1.72B | 37.35 | 1.41B | 2.14B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.85977 | -0.16 | -2.01977 | 1262.36% |
| FQ1 2025 (Mar 2025) | -0.0029 | -0.0029 | 100% | |
| FQ4 2024 (Dec 2024) | 0.29 | 0.29 | 100% | |
| FQ3 2024 (Sep 2024) | -9.45 | -9.45 | 100% | |
| FQ2 2024 (Jun 2024) | -3.94 | -3.94 | 100% | |
| FQ1 2024 (Mar 2024) | -1.4 | -1.4 | 100% | |
| FQ4 2023 (Dec 2023) | -5.26 | -5.26 | 100% | |
| FQ3 2023 (Sep 2023) | 2.58 | 2.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $1.57B | $1.33B | $-240.97M | -18.12% |
| FQ1 2025 (Mar 2025) | $0B | $1.08B | $1076.88M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.23B | $1231.71M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.35B | $1354.69M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.43B | $1430.39M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.36B | $1360.74M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.36B | $2356.17M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $2.31B | $2310.6M | 100% |